På basis af den begrænsede mængde oplysninger om virkning og sikkerhed, der var indsendt, konkluderede Udvalget for Humanmedicinske Lægemidler (CHMP), at Carbaglu var effektivt til at reducere ammoniumniveauer i blodet til normale niveauer.
On the basis of the limited information on effectiveness and safety that was submitted, the Committee for Medicinal Products for Human Use (CHMP) concluded that Carbaglu was effective in reducing blood ammonia to normal levels.